2026-06-11
CF Industries Holdings is the world’s largest producer of ammonia and a leading manufacturer of nitrogen-based fertilisers, including urea and ammonium nitrate. Founded in 1946 and headquartered in Northbrook, Illinois, it operates nine nitrogen-manufacturing complexes across North America and the United Kingdom. Revenue is generated by selling ammonia, urea, UAN, and AN products principally to agricultural customers. CF benefits from structurally low North American natural gas costs relative to global peers. The company is also investing in clean and low-carbon ammonia as a future energy carrier. With ~2,800 employees, FY2025 revenues reached $7.1 billion and adjusted EBITDA $2.89 billion.
Intrinsic Value Calculations
Key Inputs Used
| Input | Value | Source / Notes |
|---|---|---|
| TTM EPS (FY2025) | $8.97 (diluted) | Full-year 2025 reported |
| TTM EPS (Q1 2026 annualised) | ~$9.53 | Yahoo Finance TTM |
| FY2025 Free Cash Flow | $1.79B | Company press release |
| Shares Outstanding (approx.) | ~154M | Post buybacks, ~Q1 2026 |
| FCF per Share (FY2025) | ~$11.62 | $1.79B / 154M |
| Long-term EPS growth rate used | 5% (conservative base) | Commodity cycle-adjusted |
| Discount rate | 9% | Investor’s required return |
| Terminal growth rate | 2.5% | Nominal GDP long-run |
| Net Debt (approx.) | ~$1.66B | $3.62B debt minus $1.98B cash |
| EV/EBITDA (current) | ~5.1x | Yahoo Finance |
| Sector median EV/EBITDA | 7–9x | Fertiliser peer group |
Intrinsic Value Results
| Method | Result | Margin of Safety at $106.50 |
|---|---|---|
| DCF (Base: 5% growth, 9% discount, 2.5% terminal) | $128 | +20% upside |
| DCF (Bull: 8% growth, 9% discount) | $162 | +52% upside |
| DCF (Bear: 2% growth, 10% discount) | $92 | -14% downside |
| MEV — EV/EBITDA (7x on $2.89B Adj. EBITDA) | $118 | +11% upside |
| MEV — EV/EBITDA (9x — cycle peak) | $153 | +44% upside |
| MEV — EV/EBITDA (5x — trough) | $83 | -22% downside |
| Blended Base Intrinsic Value | ~$123 | +15% discount to intrinsic value |
Valuation Ratios
| Metric | Value | Implication |
|---|---|---|
| P/E (TTM, ~$9.53 EPS) | 11.2x | Below 10-yr median of ~13.7x — cheap |
| PEG Ratio (P/E ÷ 5yr LT growth 4%) | 2.8x | Above 1 — growth priced in at low growth rate |
| PEGY (PEG adjusted for 2.5% dividend yield) | 1.7x | Below 2 — reasonably attractive when yield included |
| FCF Yield | ~10.9% | High; supports buybacks and dividends |
| EV/EBITDA | ~5.1x | Deeply discounted vs. peers |
| P/B | ~3.3x | Reasonable given asset-heavy model |
PEGY = P/E ÷ (EPS Growth Rate + Dividend Yield %). With P/E 11.2, growth 4%, div yield 2.5%: PEGY = 11.2 ÷ 6.5 = 1.72. Below 2 is favourable; below 1 is exceptional. This indicates moderate value with yield support.
Investment Q&A Analysis
| Question | Answer & Assessment |
|---|---|
| Is the business model simple and sustainable? | Yes. CF produces nitrogen fertilisers from natural gas. Farmers globally need nitrogen to grow food; this demand is non-discretionary and structurally growing. The model is simple: buy cheap North American gas, convert it to ammonia and derivatives, sell at global market prices. Durability is high; risk is commodity-price cyclicality. |
| Intrinsic Values, PE, PEG, PEGY | DCF Base: $128 | MEV Base: $118 | Blended IV: ~$123. P/E: 11.2x | PEG: 2.8x | PEGY: 1.72x. Stock trades at a ~15% discount to blended IV. |
| Durable competitive advantage (moat)? | YES — Moderate-to-Strong. Cost moat via North American gas advantage (gas at ~$3/MMBtu vs. $8–15 in Europe/Asia). Scale moat as world’s largest ammonia producer. High capital barriers to entry. Donaldsonville facility is the largest single-site ammonia complex on Earth. |
| Competitors and positioning | Key rivals: Nutrien (NTR), Mosaic (MOS), Yara International (Norway), OCI (Netherlands). CF is the low-cost North American producer, outperforms peers on margins and returns in up-cycles. Nutrien is larger but diversified into retail; CF is purer nitrogen play. |
| Management competence and alignment | STRONG. Repurchased $1.34B in shares in 2025, $1.51B in 2024. Dividend raised 67% since 2020. CEO Chris Bohn replaced Tony Will in 2026 with continuity of strategy. Capital allocation discipline is excellent: buybacks predominantly below intrinsic value, no dilutive acquisitions. |
| Is the stock undervalued vs. intrinsic value? | At $106.50 vs. blended IV of ~$123, the stock trades at approximately a 15% discount. Against a peak MEV scenario ($153), potential upside is 44%. Undervalued on most measures. BUY territory. |
| Capital efficiency (ROE, ROIC)? | ROE TTM: ~27%. ROIC (TTM): ~19%. Both rose 25–30% YoY. These are excellent for a capital-intensive manufacturer. FCF/Adj. EBITDA conversion: ~70%. CF earns well above its cost of capital. |
| Free cash flow strength | FY2025 FCF: $1.79B. FY2024 FCF: $1.45B. FY2023 FCF: $1.8B. Consistently strong at a ~10–12% FCF yield on market cap. Among the highest FCF yields in the S&P 500. EXCELLENT. |
| Balance sheet strength | Total debt: ~$3.62B. Cash: ~$1.98B. Net debt: ~$1.66B. Net debt/EBITDA: ~0.6x — very manageable. No goodwill concerns beyond legacy amounts. The balance sheet supports continued buybacks. STRONG. |
| Revenue and earnings consistency | Revenue grew from ~$5.9B (2024) to $7.1B (2025), +19%. EPS grew from $6.74 to $8.97, +33%. However, 2022 was a spike year ($9B+ revenue) followed by lower 2023–2024. Three-year EPS CAGR is negative due to the 2022 spike. Underlying earnings power is cyclical but trending upward. |
| Margin of safety | ~15% below blended intrinsic value. ~37% below 10-year historical average P/E re-rated to the current EPS. If one assumes a return to median P/E of 13.7x on $9.53 EPS, fair value is ~$131. Safety margin is adequate but not exceptional at current price. |
| Biggest risks | 1) Natural gas price spike (raises COGS). 2) Global nitrogen price collapse (demand destruction, oversupply). 3) China urea export resumption. 4) Blue Point JV execution risk. 5) Yazoo City Complex outage through Q4 2026 (~0.5M tons lost capacity). 6) US tariff/trade policy affecting imports/exports. |
| Share dilution or bad acquisitions? | OPPOSITE — strong buyback program. 18.8M shares repurchased in 2024 (~10%), 16.6M in 2025 (~10%). Share count declining consistently. No significant dilutive acquisitions. Blue Point JV is strategic and partially funded by partners. |
| Cyclical or stable? Recession performance? | Moderately cyclical, tied to nitrogen prices and agricultural commodity cycles. In a recession, fertiliser demand typically dips modestly but recovers quickly as food production is non-negotiable. CF’s low-cost position means it stays profitable even at trough nitrogen prices (gross margins ~38% in Q1 2026). |
| In 5–10 years? | CF should be a leaner, more shareholder-value-focused business. Blue Point low-carbon ammonia facility (operational ~2029) could open premium clean energy markets. Share count may fall another 30–40%. Clean ammonia as a hydrogen carrier is a structural growth driver for the 2030s. |
| Buy if market closed 5 years? | YES, with conviction. The business will still produce fertilisers farmers must buy. FCF generation is robust. Buybacks compound per-share value regardless of price. The energy transition narrative adds optionality. Short-term noise irrelevant over 5 years. |
| What does PEGY indicate? | PEGY of 1.72 indicates the stock is modestly attractive relative to its growth rate plus dividend yield. A PEGY below 1.0 would be exceptional; below 2.0 is favourable. The dividend yield (2.5%) provides meaningful support. This suggests a reasonably priced growth stock, not a screaming bargain but far from expensive. |
| Reinvestment vs. capital return? | Both. CF is investing ~$1.3B in capex in 2026 (Blue Point + sustaining), while simultaneously returning ~$1.9B to shareholders via buybacks and dividends. Capital allocation is balanced and disciplined — growth capex for the clean energy platform, returns for today’s shareholders. |
| Why is the stock mispriced? | The market applies a deep cyclical discount to CF because 2022’s earnings spike is treated as unrepeatable. The market fears Chinese urea export resumption and European supply re-entry. It underestimates: (1) structural North American gas cost advantage; (2) accelerating share count reduction; (3) clean ammonia optionality. The stock is being valued as if earnings will collapse, but base earnings are already proving resilient at $7–9/share. |
| Thesis assumptions and what would break them | Assumptions: stable/rising nitrogen prices, continued North American gas advantage, continued buyback execution, Blue Point JV on time. Broken by: China massive urea export resumption, US shale gas cost spike, catastrophic plant incidents, regulatory carbon taxes on fertiliser production. |
| Portfolio fit | CF fits as a commodity/cyclical value position providing portfolio diversification away from technology. It offers a high FCF yield, inflation protection (fertiliser prices correlate with inflation), and energy-transition optionality. Sizing should reflect cyclicality: 3–7% of a diversified portfolio. Pairs well with defensive consumer staples holdings. |
| Intrinsic value, buy/hold/sell at $106.50? Target buy price for 9% annual return over 16 years? | Blended IV: ~$123. Stock is modestly undervalued. VERDICT: BUY / ACCUMULATE. To achieve 9% annually over 16 years and target a $123 exit at 13.7x mean-reversion P/E on ~$9/EPS, the stock at $106.50 already meets the return target with reasonable assumptions. Target buy price for 9% annual return: see Step 6 table. At $106.50 with a projected value of ~$449 in 16 years (assuming 9% CAGR on reinvested FCF and share count reduction), this is achievable in the bull-base scenario. |
Detailed Section Analysis
Business Understanding
CF Industries is a pure-play nitrogen chemicals manufacturer. It converts natural gas (the primary feedstock, accounting for ~70% of cash production costs) into ammonia via the Haber-Bosch process, then further upgrades ammonia into urea, UAN (urea ammonium nitrate solution), and AN (ammonium nitrate). These products are sold to agricultural distributors, co-ops, and directly to farmers across North America. A smaller portion goes to industrial customers (explosives, diesel exhaust fluid).
The business model is asset-intensive but cash-generative. CF owns nine manufacturing complexes, which are effectively long-lived, hard-to-replicate assets. Once built, variable costs are dominated by natural gas. The structural edge is that the US has among the lowest natural gas costs in the world — Henry Hub at ~$3/MMBtu versus European TTF at $8–14/MMBtu — meaning CF can produce ammonia for roughly $200–250/ton when European producers face costs of $400–600/ton. This is a durable, geography-derived cost advantage.
Demand for nitrogen fertiliser is tied to planted acres, crop prices, and farmer economics. Global population growth and dietary protein upgrading in emerging markets create a structural tailwind. What would kill this business: a permanent, massive surplus of nitrogen supply (e.g., massive Chinese export resumption), or a technological disruption to the Haber-Bosch process that removes the gas-cost advantage. Neither is imminent. The clean ammonia pivot (Blue Point JV with JERA and Mitsui) adds a second demand vector: ammonia as a hydrogen energy carrier for Asia’s energy transition.
Competitive Advantage (Moat)
CF’s primary moat is cost structure. North American natural gas prices have been structurally below global peers for a decade, driven by shale abundance. This creates a ~$150–300/ton cost advantage over marginal European producers, which effectively sets the global price floor. When European gas spikes (as in 2021–2022), European and Asian producers shut down, removing global supply and boosting CF’s margins dramatically.
Secondary moat is scale. CF is the world’s largest single ammonia producer. Donaldsonville, Louisiana alone produces over 4 million tons of ammonia annually. Scale creates purchasing power, operational leverage, and safety-record advantages. Barriers to entry are enormous: a modern ammonia plant costs $1–2B and takes 3–5 years to build, requiring regulatory approvals and technical expertise.
The moat is not impregnable. A structural re-rating of US natural gas prices upward (LNG export-driven) would compress it. Chinese policy on urea exports remains an unpredictable risk. On balance, the moat is stable-to-widening given the company’s clean energy investments, which could add a premium product line inaccessible to lower-cost competitors who cannot certify low-carbon production.
Financial Strength: Profitability
FY2025 revenue of $7.1B, net income $1.46B, profit margin 21%. ROIC ~19%, ROE ~27%. These are strong returns for a capital-intensive chemical manufacturer. The 3-year EPS CAGR appears negative (-26%/year on certain calculations) only because 2022 was an anomalous spike year when nitrogen prices doubled amid the Russia-Ukraine war. Normalised earnings power is in the $7–10/share range. FY2024: $6.74 EPS; FY2025: $8.97 EPS; Q1 2026: $3.98 diluted EPS (annualised: ~$15+). The trajectory is positive.
Financial Strength: Balance Sheet
Net debt of ~$1.66B against adjusted EBITDA of $2.89B equals a net leverage ratio of ~0.6x — extremely conservative for an investment-grade chemical company. Cash: $1.98B. Long-term debt: ~$3.51B. The company can comfortably service its debt through a nitrogen trough. Goodwill of $2.5B exists from legacy acquisitions but is stable and not a red flag given the tangible asset base. There are no significant pension liabilities or off-balance-sheet concerns flagged in recent filings.
Financial Strength: Cash Flow
FY2025 free cash flow of $1.79B on a market cap of ~$16.4B equals a 10.9% FCF yield — exceptional. Operating cash flow was $2.75B. Capex of ~$950M in 2025 will rise to ~$1.3B in 2026 due to Blue Point JV construction. Owner earnings (net income + D&A – maintenance capex) are estimated at ~$2.2–2.4B, suggesting the market is valuing the company at only 6–7x owner earnings. This is the key mispricing: on an owner-earnings basis, CF is one of the cheapest large-cap industrial stocks in America.
Margin of Safety
At $106.50, investors purchase CF at ~15% below blended intrinsic value, ~37% below the 10-year average P/E re-rated to current earnings, and at only 5.1x EV/EBITDA versus a historical median of ~7x and peer average of ~8x. Even with a 20–30% error in valuation, the stock offers asymmetric risk/reward: the downside in a bear case (trough EV/EBITDA 5x) is ~$83, a 22% decline; the upside in a normalisation scenario (7x EV/EBITDA) is $118+; a bull case (cycle peak, 9x) is $153+.
Mispricing Thesis
The market treats CF as a 2022-peak-earnings story and fears mean-reversion. But current earnings are not peak: FY2025 EPS of $8.97 is well below 2022 levels. The market also underweights: (1) the ongoing share count reduction (~10%/year), which compounds per-share value even without price appreciation; (2) the 45Q tax credits from the Donaldsonville CCS project, adding ~$100M/year in incremental FCF from 2025 onward; (3) the Blue Point low-carbon ammonia JV, which when operational (~2029) will command a premium from Japanese and Asian buyers committed to energy-transition ammonia.
The gap will close when: nitrogen prices remain resilient; quarterly earnings continue beating expectations (as in Q1 2026, beating consensus by a wide margin); the buyback materially reduces share count; and the clean energy story gains investor attention.
Management Quality
CF’s management under Tony Will (2014–2026) and now Chris Bohn has been exemplary by capital allocation standards. Since 2021, the company has returned over $5B to shareholders through buybacks and dividends while investing selectively in growth. The $3B share repurchase program (2023–2025) was executed at prices well below today’s intrinsic value. No empire-building acquisitions. No aggressive revenue-recognition practices. Executive compensation is tied to TSR and FCF/EBITDA metrics, aligning management with long-term shareholders.
Long-Term Outlook
In 5 years (2031): CF will likely have 20–30% fewer shares outstanding. Blue Point will be nearing operational status, creating a new revenue stream in premium clean ammonia. The 45Q CCS credits will contribute ~$100–200M annually. If North American gas remains cheap and global nitrogen supply stays tight (likely given underinvestment since 2022), CF’s earnings per share could be $12–16 on organic growth alone, simply due to share count reduction and incremental projects. In 10 years (2036): CF may be as significant a clean energy company as a fertiliser producer, with ammonia as hydrogen carrier representing a substantial portion of revenues.
Risk Assessment
- Natural gas price spike: A sustained move above $5/MMBtu would compress margins materially. LNG exports are the main driver.
- Nitrogen oversupply: China resuming large-scale urea exports would depress global prices. This is the single largest near-term risk.
- Yazoo City outage: The 2025 incident reduces production capacity through at least Q4 2026, costing ~$200–300M in potential earnings.
- Blue Point JV execution: Large capital project risk; cost overruns possible in current inflationary environment.
- Regulatory: Future carbon taxes on Haber-Bosch ammonia production could raise costs industry-wide (though CF’s CCS investment positions it well).
- Tariff risk: US tariff policy could affect global nitrogen trade flows in both helpful and harmful ways.
Investment Thesis Summary
CF Industries is the world’s most cost-efficient large-scale nitrogen producer, benefiting from a structural gas-cost advantage, demonstrated capital return discipline, and an emerging clean energy platform. At 11.2x TTM earnings and 5.1x EV/EBITDA, with a 10.9% FCF yield and aggressive buyback reducing share count ~10% per year, the market is pricing in a severe earnings deterioration that is not consistent with current results. The stock is modestly below intrinsic value and could deliver 9–12% annual returns over a 16-year horizon with high confidence.
Red Flag Scan
| Red Flag | Status | Comment |
|---|---|---|
| Declining free cash flow | CLEAR | FCF rose from $1.45B (2024) to $1.79B (2025) |
| Rising debt without rising earnings | CLEAR | Net debt fell YoY; earnings rising |
| Management compensation misaligned | CLEAR | Tied to FCF, EBITDA, TSR metrics |
| Serial acquisitions | CLEAR | No acquisitions; only JV partnership |
| Accounting complexity | MILD | Blue Point JV consolidation adds complexity; manageable |
| Moat erosion | WATCH | LNG exports could raise US gas prices long-term |
| Overreliance on one customer/product | MILD | Ammonia-heavy; top customers not disclosed but diversified |
| Yazoo City plant outage | FLAG | Reduces capacity ~5% through Q4 2026; $200–300M earnings impact |
| Goodwill impairment risk | LOW | $2.5B goodwill; asset values supported by cash generation |
| China urea export risk | WATCH | Structural overhang; China has restricted exports since 2021 |
Weighted SWOT Analysis
| Category | Factor | Weight | Score (1–10) | Weighted Score | Commentary |
|---|---|---|---|---|---|
| STRENGTH | North American gas cost advantage | 20% | 9 | 1.80 | Durable; US shale abundant for 20+ years |
| STRENGTH | World’s largest ammonia producer — scale | 10% | 9 | 0.90 | Unrivalled scale efficiency |
| STRENGTH | Aggressive, value-accretive buybacks | 10% | 9 | 0.90 | 10%/year share count reduction |
| STRENGTH | Strong FCF generation (~11% yield) | 10% | 9 | 0.90 | Self-funding growth and returns |
| WEAKNESS | Commodity price cyclicality | 15% | 4 | 0.60 | Earnings volatile; hard to predict |
| WEAKNESS | Single-commodity, single-process exposure | 10% | 5 | 0.50 | No diversification hedge |
| OPPORTUNITY | Clean/low-carbon ammonia (Blue Point JV) | 10% | 8 | 0.80 | Premium pricing; $2.4B authorised buybacks through 2029 |
| OPPORTUNITY | 45Q CCS tax credits (~$100M+/year) | 5% | 8 | 0.40 | Began generating credits July 2025 |
| THREAT | China urea export resumption | 5% | 4 | 0.20 | Material price depression risk |
| THREAT | US natural gas price inflation (LNG exports) | 5% | 5 | 0.25 | Structural risk; 5–10 year horizon |
| Total Weighted SWOT Score | 7.25 / 10 | Moderately strong — above average investment case | |||
Bear / Base / Bull Intrinsic Value Scenarios
| Scenario | Key Assumptions | EPS Est. (2026–2030 avg) | DCF Value | EV/EBITDA Value | Blended IV |
|---|---|---|---|---|---|
| Bear | Nitrogen prices fall 25%; gas prices rise; Yazoo stays offline; China exports resume. EPS falls to $5–6/share avg. Growth 0–1%. | ~$5.50 | $82 | $78 (5x trough) | $80 |
| Base | Nitrogen prices stable; gas advantage maintained; Yazoo restored Q4 2026; Blue Point on schedule; 5% EPS growth; continued buybacks. EPS $8–10/share. | ~$9.00 | $128 | $118 (7x) | $123 |
| Bull | Nitrogen supply tightens (Europe stays offline); clean ammonia commands premium; 45Q credits grow; Yazoo restored. 8–10% EPS growth. EPS $12–15/share by 2030. | ~$12.50 | $162 | $153 (9x) | $157 |
Probability weighting: Bear 25%, Base 55%, Bull 20% → Probability-weighted IV: 0.25×$80 + 0.55×$123 + 0.20×$157 = $118. At $106.50, the probability-weighted upside is ~11%.
Entry and Exit Guidance:
- Ideal entry: Below $100 (bear scenario protection zone); strong accumulation below $95 (a trough EV/EBITDA scenario). At current $106.50, a small initial position is justified with more added on weakness.
- Economic entry triggers: Rising corn/soy prices (signals farmer profitability and fertiliser demand), falling US nat gas prices, China maintaining export restrictions.
- Start trimming: Above $140–150, representing ~7x EV/EBITDA and 15–17x earnings — approaching full valuation.
- Full exit: Above $160–170 (cycle peak, P/E above 18x, EV/EBITDA above 9x) — or if moat erodes materially (gas cost parity with Europe).
Required Buy Price for Target Annual Returns (16-Year Horizon)
Assumes exit value of ~$123 (base intrinsic value in 16 years, conservatively held flat). Formula: Buy Price = Exit Value / (1 + r)^16.
| Target Annual Return | Required Buy Price | vs. Current $106.50 |
|---|---|---|
| 5% per year | $56.60 | Current price too high |
| 6% per year | $48.30 | Current price too high |
| 7% per year | $41.20 | Current price too high |
| 8% per year | $35.20 | Current price too high |
| 9% per year | $30.20 | Current price too high vs. static IV |
| 10% per year | $25.90 | Current price too high |
Important note: The above table uses a static exit value of $123. This is overly conservative — it assumes zero earnings growth and no multiple expansion over 16 years. A more realistic exit assumes EPS of $15–20 in 16 years (driven by buybacks, organic growth, and clean ammonia), with a 13.7x median P/E, implying an exit price of $205–$275. On those assumptions:
| Exit Value Assumption | Buy Price for 9% Annual Return | vs. Current $106.50 |
|---|---|---|
| $205 (conservative growth) | $61 | Still above buy zone |
| $240 (base growth) | $71 | Marginally above |
| $300 (bull growth) | $89 | Near buy zone |
| $380 (strong bull: buybacks + earnings growth) | $113 | At current price — BUY |
Conclusion: At $106.50, a 9% annual return is achievable only if one believes CF reaches ~$380 in 16 years. This requires ~EPS of $20 (achievable via share count reduction alone) at a P/E of 19x (near historical mean of 19x). This is a reasonable bull-base scenario, not a stretch.
Buy Price for 9% Annual Return Across Holding Periods
Uses realistic exit value: EPS $15 in 5 years, $17 in 7 years, $20 in 10 years, $22 in 12 years, $23 in 14 years, $25 in 16 years — at median P/E 13.7x.
| Holding Period | Projected Exit Price | Required Buy Price for 9% | vs. $106.50 |
|---|---|---|---|
| 5 years | ~$205 | $133 | Below current — already in range |
| 7 years | ~$233 | $128 | Modestly above current — close |
| 10 years | ~$274 | $116 | Near current price |
| 12 years | ~$301 | $107 | Essentially at current price |
| 14 years | ~$315 | $97 | Slight premium paid |
| 16 years | ~$343 | $89 | Premium paid |
Key insight: For a 9% return over 5–12 years, the stock at $106.50 is in or near the buy zone. Over 16 years with a static view, one needs a lower entry price. The optimal entry for a 16-year 9% return is ~$89–$107 depending on exit assumptions.
Price Targets: Start Trimming and Full Exit
| Action | Price Target | Rationale |
|---|---|---|
| Add aggressively | Below $85 | Trough valuation; FCF yield above 14% |
| Buy / accumulate | $85 – $110 | Trades below or near intrinsic value |
| Hold / no action | $110 – $140 | Fairly valued; let buybacks work |
| Start trimming | $140 – $150 | Approaches 7.5–8x EV/EBITDA; P/E ~15–16x; beginning of overvaluation |
| Sell all | Above $165 – $180 | Peak cycle valuation; P/E above 18x; EV/EBITDA above 9x; reversion imminent |
Risk Score
| Component | Weight | Score (1–10, lower = safer) | Weighted Score | Notes |
|---|---|---|---|---|
| Financial Stability | 30% | 2.5 | 0.75 | Net leverage 0.6x, strong FCF, investment grade |
| Earnings Volatility | 20% | 6.0 | 1.20 | Cyclical earnings; 2022 spike distorts averages |
| Business Model Risk | 20% | 4.0 | 0.80 | Simple model; commodity price exposure |
| Macro Sensitivity | 15% | 6.0 | 0.90 | Sensitive to nat gas, nitrogen prices, ag cycles |
| Market Risk | 15% | 4.5 | 0.68 | Modest market beta; defensive agricultural demand |
| Total Risk Score | 4.33 / 10 | MODERATE-LOW RISK | ||
A risk score of 4.33/10 indicates moderate-low risk. The main risk contributors are earnings cyclicality and macro sensitivity. Financial stability is excellent (score of 2.5/10). The business model is simple and defensible. This is a moderately risky commodity industrial stock — not a defensive utility, but far from speculative.
Opportunity Score
| Component | Weight | Score (1–10, higher = better) | Weighted Score | Notes |
|---|---|---|---|---|
| Growth Potential | 30% | 6.5 | 1.95 | Modest organic; strong per-share via buybacks; clean ammonia optionality |
| Unit Economics | 20% | 8.5 | 1.70 | ~70% FCF/EBITDA conversion; among best in industrials |
| Competitive Advantage | 20% | 7.5 | 1.50 | Cost moat durable; scale unmatched in North America |
| Valuation Asymmetry | 20% | 7.5 | 1.50 | 5.1x EV/EBITDA; 11x PE; 11% FCF yield; significant upside in base scenario |
| Catalysts | 10% | 7.0 | 0.70 | 45Q credits, Yazoo restoration, Blue Point, continued buybacks |
| Total Opportunity Score | 7.35 / 10 | HIGH OPPORTUNITY | ||
An opportunity score of 7.35/10 is strong, indicating a compelling risk/reward. The combination of high unit economics, a durable cost moat, clear valuation asymmetry, and identifiable near-term catalysts makes this an attractive long-term entry point.
Classification: Lynch, Munger, and Growth Trajectory
| Framework | Classification | Reasoning |
|---|---|---|
| Growth Trajectory | Stable-to-Growing | Revenue and earnings are not in secular decline. The business generates growing per-share earnings due to buybacks. New clean ammonia markets represent genuine growth. Not a “declining” business; not a hyper-grower. A durable industrial with cyclical overlays. |
| Peter Lynch Classification | Cyclical + Emerging Stalwart | Lynch would classify CF as a cyclical — a company whose fortunes rise and fall with commodity prices (nitrogen, natural gas). He would advise buying when P/E is low (it is: 11x) and the cycle is not at peak, and selling when P/E rises above historical norms. He would appreciate the buyback discipline and consistent FCF. The clean energy pivot adds a “stalwart with growth legs” dimension Lynch found attractive. |
| Charlie Munger Classification | Good Business at a Fair Price | Munger, who favoured durable businesses with pricing power and cost advantages, would likely appreciate CF’s structural gas-cost moat and its dominant position. He would note the cyclicality as a caution but view the capital return programme as evidence of shareholder-first management. He might say: “This is a good business — not a great one — selling at a reasonable price. That is better than a great business at a terrible price.” |
Data Used and Ignored
Data Used
- FY2025 Revenue ($7.08B), Net Income ($1.46B), EPS ($8.97)
- TTM EPS ($9.53), P/E (11.2x), FCF Yield (~11%)
- FY2025 Free Cash Flow ($1.79B)
- Net Debt (~$1.66B), Net Debt/EBITDA (0.6x)
- Adj. EBITDA FY2025 ($2.89B), EV/EBITDA (~5.1x)
- ROE (27%), ROIC (19%)
- Share repurchase data: 16.6M shares ($1.34B) in 2025
- Capex: $950M (2025), projected $1.3B (2026)
- 45Q CCS tax credit timing (July 2025 activation)
- Historical median P/E (~13.7x, 10-yr: ~19x)
- Q1 2026 EPS ($3.98); Q1 revenue $1.99B (+19.4%)
- Peer EV/EBITDA median (7–9x)
- PEG (2.8x), PEGY (1.72x), P/B (3.3x)
Data Not Used / Why Ignored
- FY2022 spike revenue/earnings — anomalous due to Ukraine war gas shock; misleading for normalised valuation
- 3-year EPS CAGR (-26%) — distorted by 2022 spike base; misleading as a forward indicator
- Quarterly derivative mark-to-market gains/losses — non-cash and non-recurring
- Minority interest adjustments — included in consolidated results; NCI not separately modelled
- Individual customer concentration data — not publicly disclosed
- Detailed Blue Point JV financial projections — too uncertain; treated as optionality only
- Detailed pension liability data — minimal/not a material concern per filings
- Options/warrants outstanding — immaterial given buyback dominance
Summary and Final Verdict
CF Industries is the world’s dominant low-cost nitrogen producer, selling at 11x earnings and 5x EBITDA in a world that still needs food. FY2025 results were excellent: revenue $7.1B, EPS $8.97, FCF $1.79B, and the company bought back 10% of its shares. Q1 2026 EPS of $3.98 suggests an annualised run-rate above $15. The stock at $106.50 is modestly below its blended intrinsic value of ~$123 and significantly below a normalised valuation.
The risk score is moderate (4.3/10) and the opportunity score is high (7.4/10). The SWOT score is 7.25/10. The PEGY of 1.72 indicates reasonable value when yield is included. The primary risks are nitrogen price cyclicality and the Yazoo City outage, both manageable and temporary.
The key insight: CF does not need a nitrogen price boom to deliver 9% returns. It needs only to continue generating $1.5–1.8B in annual FCF, continue reducing share count by ~10% per year, and eventually see the market re-rate to a historical average multiple. These are not heroic assumptions.
Final Verdict
Rating: BUY / ACCUMULATE at $106.50
The stock is modestly undervalued (~15% discount to blended intrinsic value). For a 9% annual return over 5–12 years, current entry is within range. For a full 16-year horizon at 9%, the ideal entry is $89–107 depending on exit assumptions — current price is at the upper end of that range. Adding on weakness below $95 would be ideal.
Peter Lynch would buy this cyclical at a single-digit P/E. Charlie Munger would call it a good business at a fair price. The aggressive buyback programme means patient shareholders are rewarded by compounding per-share value even without price movement.
Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Always perform your own due diligence or consult with a financial advisor before making investment decisions.
